![Actinogen Medical Limited logo](/logos/ACW.AX.webp)
Actinogen Medical Limited
ASX:ACW.AX
Overview | Financials
Company Name | Actinogen Medical Limited |
Symbol | ACW.AX |
Currency | AUD |
Price | 0.039 |
Market Cap | 93,168,965 |
Dividend Yield | 0% |
52-week-range | 0.015 - 0.099 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D. |
Website | https://www.actinogen.com.au |
An error occurred while fetching data.
About Actinogen Medical Limited
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD